Targeting Vascular Injury Using Hantavirus-Pseudotyped Lentiviral Vectors
Open Access
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (4) , 694-704
- https://doi.org/10.1016/j.ymthe.2005.11.016
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Improved Vascular Gene Transfer With a Helper-Dependent Adenoviral VectorCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- In VivoTargeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral VectorsHuman Gene Therapy, 2003
- Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapyJournal of Molecular and Cellular Cardiology, 2003
- Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivoBlood, 2002
- Development of lentiviral vectors for antiangiogenic gene deliveryCancer Gene Therapy, 2001
- High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransductionGene Therapy, 1999
- Adenovirus-Mediated Gene Transfer Is Augmented in Basilar and Carotid Arteries of Heritable Hyperlipidemic RabbitsStroke, 1999
- Adenovirus-Mediated Gene Transfer to Lower Limb Artery of Patients with Chronic Critical Leg IschemiaHuman Gene Therapy, 1998
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996